Role of iron in the potentiation of anthracycline cardiotoxicity: Identification of heart cell mitochondria as a major site of iron-anthracycline interaction-Reference-Cited by-同舟云学术

Role of iron in the potentiation of anthracycline cardiotoxicity: Identification of heart cell mitochondria as a major site of iron-anthracycline interaction

Published:1996-03 Issue:3 Volume:127 Page:272-278
ISSN:0022-2143
Container-title:Journal of Laboratory and Clinical Medicine
language:en
Short-container-title:Journal of Laboratory and Clinical Medicine

Author:

Link Gabriela,Tirosh Regine,Pinson Arie,Hershko Chaim

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference43 articles.

1. The anthracycline antineoplastic drugs;Young;N Engl J Med,1981

2. Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture;Hershko;J Lab Clin Med,1993

3. Heart cells in culture: a model of myocardial iron overload and chelation;Link;J Lab Clin Med,1985

4. Ultrastructural pathology of iron-loaded rat myocardial cells in culture;Iancu;Br J Exp Pathol,1987

5. Iron overload in cultured rat myocardial cells;Bauminger;Hyperfine Interact,1987

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Silymarin protects against doxorubicin induced cardiotoxicity by down-regulating topoisomerase IIβ expression in mice;Biotechnic & Histochemistry;2023-06-05

2. Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity;Oxidative Medicine and Cellular Longevity;2022-08-03

3. Development and Validation of a Diagnostic Nomogram to Predict the Anthracycline-Induced Early Cardiotoxicity in Children with Hematological Tumors;Cardiovascular Toxicology;2022-06-16

4. Relevance of Ferroptosis to Cardiotoxicity Caused by Anthracyclines: Mechanisms to Target Treatments;Frontiers in Cardiovascular Medicine;2022-06-13

5. Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity;Frontiers in Cardiovascular Medicine;2022-01-24